ProCE Banner Series

Cultivating Inclusivity: Paving the Path to Improved Diversity in Clinical Trials

This program aims to explore the critical importance of improving diversity and inclusivity in clinical trials so the results are generalizable and applicable to real-world patients encountered in clinical practice. Through insightful conversations and real-world examples, we aim to inspire a shift toward greater diversity, ensuring that clinical trials reflect the rich tapestry of the patient populations being treated.

  ACPE
  | AMA
  | ANCC
Who Should Attend

This program is intended for HCPs who care for psychiatric patients and/or contribute to research efforts in clinical psychopharmacology, including psychiatrists, nurse practitioners, physician associates, pharmacists, nurses, psychologists, and social workers.

All Events

Cultivating Inclusivity: Paving the Path to Improved Diversity in Clinical Trials

Upcoming Events

May

29

2024

7:00 PM - 8:30 PM Eastern Time (ET)

In-person

Loews Miami Beach Hotel, 1601 Collins Ave., Miami Beach, Florida 33139

7:30 PM - 8:30 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Crystal T. Clark, MD, MSc

Psychiatrist
Associate Professor
Department of Psychiatry
University of Toronto
Associate Head of Research
Women’s College Hospital
Toronto, Ontario, Canada

ProCE Banner Faculty
Francisco Moreno, MD

Scientific Consultant
Tenured Professor of Psychiatry
College of Medicine Tucson
Associate Vice President
University of Arizona Health Sciences
Office of Equity, Diversity, and Inclusion
Tucson, Arizona

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Psychiatry.

Target Audience
This program is intended for HCPs who care for psychiatric patients and/or contribute to research efforts in clinical psychopharmacology, including psychiatrists, nurse practitioners, physician associates, pharmacists, nurses, psychologists, and social workers.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify implications for lacking diversity in the patient populations of clinical trials
  • Formulate strategies to address barriers to diversifying patient populations in clinical trials
  • Outline the steps needed to enroll patients into clinical trials

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-24-114-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

ABMS Approval Statement

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory,  Cultivating Inclusivity: Paving the Path to Improved Diversity in Clinical Trials, has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

ABMS Lifelong Learning CME Activity

Psychiatry and Neurology

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC in partnership with American Society of Clinical Psychopharmacology.

Supported by an educational grant from Otsuka America Pharmaceutical, Inc.

American Society of Clinical Psychopharmacology (ASCP) has reviewed and approved this symposium as appropriate for presentation as an industry supported Satellite Symposium. The symposium constitutes the content and views of Clinical Care Options, LLC and ASCP.